Assetmark »

Apellis Pharmaceuticals shares owned by Assetmark

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Assetmark

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 17k 59.86
2023-09-30 $433k 11k 38.04
2023-06-30 $549k 6.0k 91.10
2023-03-31 $317k 4.8k 65.96